DCB Open Innovation Challenge: The top 3 devices have been selected
The DCB Open Innovation Challenge 2022 has reached its next stage as the DCB Innovation Jury has selected the top 3 teams of the category Diabetes Devices.
The jury together with finalist John Wilcox during the pitch day. Photo: André Raul Surace
Of the TOP 20 teams that pitched their idea to the DCB Innovation Jury last Tuesday, the following three teams were selected for the finals:
Ole Kjerkegaard Nielsen (DK) – GO-Pen: Affordable insulin pen for all
John Wilcox (US) – SmartFusion: A Next Generation Insulin Infusion Monitoring Platform
Ben Delhey (FR) – Lassie: The first non-invasive breath analyzer for people with diabetes
The three finalists will attend a one-week innovation bootcamp in Switzerland in the end of June. The final pitches and award ceremony will take place on 30 November 2022 at the sitem-insel in Bern together with the top 3 teams of the category Digital Diabetes starting mid-July. The three winning teams will receive a total price of 200,000 US dollars, along with additional support. The DCB Innovation Challenge award is one of the world’s most generous and renowned diabetes-related awards.
The DCB Innovation Jury during Pitch Day on 10 May 2022. Photos: André Raul Surace
Downloads
TOP 3 Diabetes Devices 2022
PDF, 297.04 KB
More recent news
Four DCB professorships advance research in diabetes technology
32 publications, 37 conference contributions and over CHF 6 million in research funding: the four professorships at...
SNAQ Launches the First AI Nutritionist for CGM Users Managing Diabetes
SNAQ has announced the release of its AI Nutritionist, a first-of-its-kind digital companion designed to help people...
DCB Innovation Bootcamp 2026 | Apply now!
31 Aug – 3 Sep · Emmetten, SwitzerlandAn immersive accelerator for diabetes technology founders in the Swiss AlpsWhy...


